» Articles » PMID: 34066504

Metabolic Control by DNA Tumor Virus-Encoded Proteins

Overview
Journal Pathogens
Date 2021 Jun 2
PMID 34066504
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Viruses co-opt a multitude of host cell metabolic processes in order to meet the energy and substrate requirements for successful viral replication. However, due to their limited coding capacity, viruses must enact most, if not all, of these metabolic changes by influencing the function of available host cell regulatory proteins. Typically, certain viral proteins, some of which can function as viral oncoproteins, interact with these cellular regulatory proteins directly in order to effect changes in downstream metabolic pathways. This review highlights recent research into how four different DNA tumor viruses, namely human adenovirus, human papillomavirus, Epstein-Barr virus and Kaposi's associated-sarcoma herpesvirus, can influence host cell metabolism through their interactions with either MYC, p53 or the pRb/E2F complex. Interestingly, some of these host cell regulators can be activated or inhibited by the same virus, depending on which viral oncoprotein is interacting with the regulatory protein. This review highlights how MYC, p53 and pRb/E2F regulate host cell metabolism, followed by an outline of how each of these DNA tumor viruses control their activities. Understanding how DNA tumor viruses regulate metabolism through viral oncoproteins could assist in the discovery or repurposing of metabolic inhibitors for antiviral therapy or treatment of virus-dependent cancers.

Citing Articles

The EBV Gastric Cancer Resource (EBV-GCR): A Suite of Tools for Investigating EBV-Associated Human Gastric Carcinogenesis.

Salnikov M, Wang E, Christensen E, Prusinkiewicz M, Shooshtari P, Mymryk J Viruses. 2023; 15(4).

PMID: 37112833 PMC: 10145221. DOI: 10.3390/v15040853.


GLUT1, LDHA, and MCT4 Expression Is Deregulated in Cervical Cancer and Precursor Lesions.

Reyna-Hernandez M, Alarcon-Romero L, Ortiz-Ortiz J, Illades-Aguiar B, Jimenez-Lopez M, Ocampo-Barcenas A J Histochem Cytochem. 2022; 70(6):437-446.

PMID: 35615882 PMC: 9169107. DOI: 10.1369/00221554221101662.


The Triangle Relationship Between Long Noncoding RNA, RIG-I-like Receptor Signaling Pathway, and Glycolysis.

Ren Z, Yu Y, Chen C, Yang D, Ding T, Zhu L Front Microbiol. 2021; 12:807737.

PMID: 34917069 PMC: 8670088. DOI: 10.3389/fmicb.2021.807737.


New Look of EBV LMP1 Signaling Landscape.

Wang L, Ning S Cancers (Basel). 2021; 13(21).

PMID: 34771613 PMC: 8582580. DOI: 10.3390/cancers13215451.

References
1.
Jones D, Thompson D, Munger K . Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis. Virology. 1998; 239(1):97-107. DOI: 10.1006/viro.1997.8851. View

2.
Ledl A, Schmidt D, Muller S . Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor. Oncogene. 2005; 24(23):3810-8. DOI: 10.1038/sj.onc.1208539. View

3.
Zhou H, Schmidt S, Jiang S, Willox B, Bernhardt K, Liang J . Epstein-Barr virus oncoprotein super-enhancers control B cell growth. Cell Host Microbe. 2015; 17(2):205-16. PMC: 4539236. DOI: 10.1016/j.chom.2014.12.013. View

4.
Yew P, Berk A . Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. Nature. 1992; 357(6373):82-5. DOI: 10.1038/357082a0. View

5.
Lo A, Dawson C, Young L, Lo K . The role of metabolic reprogramming in γ-herpesvirus-associated oncogenesis. Int J Cancer. 2017; 141(8):1512-1521. DOI: 10.1002/ijc.30795. View